-
The American College of Obstetricians and Gynecologists says that long-acting reversible contraception (LARC) methods are safe, effective, and appropriate options for teens, but some might perceive high discontinuation rates among younger women and therefore steer patients away from them.
-
Transdermal contraception provides a family planning option that is not dependent on daily dosing. The only transdermal contraceptive approved in the United States is the Ortho Evra patch.
-
No link seen between regimen use and increased sexual risk behavior
-
Early research indicates that women with moderate to severe menstrual cramps might find relief in vaginal administration of sildenafil citrate (Viagra, Pfizer), a drug commonly used for erectile dysfunction.
-
With Congress in a seemingly perpetual state of deadlock, one of the most anticipated actions on federal reproductive health policy will instead be taken by the U.S. Supreme Court this spring.
-
A review of 10 years of national data indicates that clinicians have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women: those who have undergone hysterectomies and those older than age 65 with no cervical cancer history.
-
-
-
The Bill & Melinda Gates Foundation has just released funding to support 11 projects that aim to improve uptake and regular use of male and female condoms by developing new designs that significantly preserve or enhance pleasure and simplify use.
-
Labeling for the European levonorgestrel (LNG) emergency contraceptive pill NorLevo has been revised due to data indicating lower drug efficacy in women weighing 165 pounds and above. This move has led U.S. regulators to assess data on similar products.
